Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1910

Jun 5, 2019

Are We Living Too Long?

Posted by in categories: biotech/medical, life extension

Medicine’s ever-increasing focus on longevity is bad for society, says a prominent physician. (But, who’d voluntarily give up those bonus years?)

Read more

Jun 5, 2019

Professor Irena Cosic PhD. — RMIT — Australia — Electromagentic Resonant Recognition Model of Macromolecular Interactions — ideaXme — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, business, DNA, genetics, health, life extension, science, transhumanism

Jun 5, 2019

Creating Thymus Organoids Using Tissue Engineering

Posted by in categories: bioengineering, biotech/medical, life extension

Today, we wish to highlight a new open access publication in which the researchers take a novel approach to the regeneration of the thymus, a small but vitally important organ that is key to our immune system.

The thymus shrinks as we age

The thymus is one of the most important organs in the body, and it is where thymocytes produced in the bone marrow travel to become new T cells before being trained in the lymph nodes to become the defenders of the adaptive immune system. However, as we get older, the thymus increasingly turns to fat and starts to shrink, causing its ability to produce new T cells to fall dramatically. This process is known as thymic involution and actually begins shortly after puberty, so this is one aspect of aging that begins fairly early in life, although it is many decades later before its decline causes serious health issues.

Continue reading “Creating Thymus Organoids Using Tissue Engineering” »

Jun 5, 2019

‘Iron Man’ actor Robert Downey Jr. has vowed to use robotics and AI to significantly clean up the Earth in the next decade

Posted by in categories: biotech/medical, robotics/AI, space

Robert Downey Jr. doesn’t pretend to be a brilliant scientist — even though he’s played Tony Stark, aka Iron Man, for the past 11 years.

But on Tuesday night he attended Amazon’s brand new, premier, open-to-the-public Machine Learning, Automation, Robotics and Space (re: MARS) conference in Las Vegas — a room filled with AI legends, astronauts, and other dignitaries — as a keynote speaker.

He delivered a gag-filled talk that somehow weaved together the history of the Marvel Cinematic Universe, the evolution of Stark’s Iron Man suits, allusions to his own troubled history with drug addiction, the actual history of artificial intelligence and its pioneers, with a bunch of jokes using the Amazon Alexa voice and Matt Damon (including a videotaped guest appearance by Damon).

Continue reading “‘Iron Man’ actor Robert Downey Jr. has vowed to use robotics and AI to significantly clean up the Earth in the next decade” »

Jun 5, 2019

Can Gene Editing Stop The Bird Flu? Here Is The Latest With Chickens

Posted by in categories: bioengineering, biotech/medical

This study shows how CRISPR gene editing can make chicken cells resistant to the avian influenza virus.

Read more

Jun 5, 2019

Deep learning techniques teach neural model to ‘play’ retrosynthesis

Posted by in categories: biotech/medical, engineering, robotics/AI, sustainability

Researchers, from biochemists to material scientists, have long relied on the rich variety of organic molecules to solve pressing challenges. Some molecules may be useful in treating diseases, others for lighting our digital displays, still others for pigments, paints, and plastics. The unique properties of each molecule are determined by its structure—that is, by the connectivity of its constituent atoms. Once a promising structure is identified, there remains the difficult task of making the targeted molecule through a sequence of chemical reactions. But which ones?

Organic chemists generally work backwards from the target molecule to the starting materials using a process called retrosynthetic analysis. During this process, the chemist faces a series of complex and inter-related decisions. For instance, of the tens of thousands of different chemical reactions, which one should you choose to create the target molecule? Once that decision is made, you may find yourself with multiple reactant molecules needed for the reaction. If these molecules are not available to purchase, then how do you select the appropriate reactions to produce them? Intelligently choosing what to do at each step of this process is critical in navigating the huge number of possible paths.

Researchers at Columbia Engineering have developed a based on reinforcement learning that trains a to correctly select the “best” reaction at each step of the retrosynthetic process. This form of AI provides a framework for researchers to design chemical syntheses that optimize user specified objectives such synthesis cost, safety, and sustainability. The new approach, published May 31 by ACS Central Science, is more successful (by ~60%) than existing strategies for solving this challenging search problem.

Continue reading “Deep learning techniques teach neural model to ‘play’ retrosynthesis” »

Jun 5, 2019

Tiny Robots Carry Stem Cells Through a Mouse

Posted by in categories: biotech/medical, robotics/AI

Using this technique, microrobots could deliver stem cells to hard-to-reach places.

Read more

Jun 5, 2019

How our immune system evolved to take control of our decision-making processes

Posted by in category: biotech/medical

Two new research papers are shedding light on the fascinating relationship between inflammation and behavior, suggesting our immune system can play a significant role in both our motivation and decision-making abilities.

Read more

Jun 5, 2019

Harvard breakthrough shows stem cells can be genetically edited in the body

Posted by in categories: biotech/medical, genetics

We owe our long lives to stem cells, which are nestled deep inside certain tissues in the body and constantly replace old cells. In recent years scientists have been able to correct genetic diseases by removing these stem cells, editing their genomes and then implanting them back into the patient, but that adds complications. Now, new research led by Harvard scientists has successfully edited the genes of stem cells while still in the body.

Read more

Jun 5, 2019

The Privacy Project

Posted by in categories: biotech/medical, business, internet

Companies and governments are gaining new powers to follow people across the internet and around the world, and even to peer into their genomes. The benefits of such advances have been apparent for years; the costs — in anonymity, even autonomy — are now becoming clearer. The boundaries of privacy are in dispute, and its future is in doubt. Citizens, politicians and business leaders are asking if societies are making the wisest tradeoffs. The Times is embarking on this monthslong project to explore the technology and where it’s taking us, and to convene debate about how it can best help realize human potential.


The New York Times is launching an ongoing examination of privacy. We’ll dig into the ideas, history and future of how our information navigates the digital ecosystem and what’s at stake.

Read more